LXRX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

12.62

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

-0.01

EPS Last/This Y

-0.04

EPS This/Next Y

-0.03

Price

1.61

Target Price

3.36

Analyst Recom

1.8

Performance Q

40.35

Upside

-213.8%

Beta

1.03

Ticker: LXRX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	LXRX	1.67	0.05	0.04	37429
2026-03-10	LXRX	1.65	0.05	0.07	37561
2026-03-11	LXRX	1.715	0.05	0.01	37539
2026-03-12	LXRX	1.705	0.05	0.01	37483
2026-03-13	LXRX	1.72	0.05	0.01	37483
2026-03-17	LXRX	1.625	0.05	0.05	37501
2026-03-18	LXRX	1.565	0.05	0.01	37584
2026-03-19	LXRX	1.615	0.05	0.01	37613
2026-03-20	LXRX	1.56	0.05	0.04	37628
2026-03-23	LXRX	1.63	0.04	0.09	31518
2026-03-24	LXRX	1.715	0.04	0.71	32534
2026-03-25	LXRX	1.685	0.04	0.01	32473
2026-03-26	LXRX	1.625	0.04	0.01	32480
2026-03-27	LXRX	1.645	0.04	0.00	32394
2026-03-30	LXRX	1.515	0.04	2.54	32706
2026-03-31	LXRX	1.56	0.06	0.00	33505
2026-04-01	LXRX	1.645	0.06	0.03	34603
2026-04-02	LXRX	1.59	0.06	0.00	34633
2026-04-06	LXRX	1.59	0.06	0.33	34740
2026-04-07	LXRX	1.605	0.06	0.00	34766
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	LXRX	1.67	50.0	-11.6	-0.18
2026-03-10	LXRX	1.65	50.0	-28.9	-0.18
2026-03-11	LXRX	1.72	50.0	-32.3	-0.18
2026-03-12	LXRX	1.71	50.0	-29.3	-0.18
2026-03-13	LXRX	1.68	50.0	-28.9	-0.18
2026-03-17	LXRX	1.62	50.0	-30.5	-0.18
2026-03-18	LXRX	1.57	50.0	-27.2	-0.18
2026-03-19	LXRX	1.62	50.0	-32.0	-0.18
2026-03-20	LXRX	1.56	50.0	-27.0	-0.18
2026-03-23	LXRX	1.63	50.0	-33.0	-0.18
2026-03-24	LXRX	1.72	50.0	-33.7	-0.18
2026-03-25	LXRX	1.68	50.0	-28.2	-0.18
2026-03-26	LXRX	1.62	50.0	-27.1	-0.18
2026-03-27	LXRX	1.64	50.0	-30.2	-0.18
2026-03-30	LXRX	1.51	50.0	-24.0	-0.18
2026-03-31	LXRX	1.56	50.0	-32.3	-0.18
2026-04-01	LXRX	1.64	50.0	-33.6	-0.18
2026-04-02	LXRX	1.59	50.0	-27.5	-0.18
2026-04-06	LXRX	1.59	50.0	-30.2	-0.18
2026-04-07	LXRX	1.61	50.0	-30.7	-0.18
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	LXRX	0.85	-29.70	13.64
2026-03-10	LXRX	0.85	-29.70	13.64
2026-03-11	LXRX	0.85	-29.70	12.87
2026-03-12	LXRX	0.85	-29.70	12.87
2026-03-13	LXRX	0.85	-29.70	12.87
2026-03-17	LXRX	0.85	-29.70	12.87
2026-03-18	LXRX	0.85	-29.70	12.87
2026-03-19	LXRX	0.85	-29.70	12.87
2026-03-20	LXRX	0.85	-29.70	12.87
2026-03-23	LXRX	0.85	-29.70	12.87
2026-03-24	LXRX	0.85	-29.70	12.87
2026-03-25	LXRX	0.85	-29.70	12.62
2026-03-26	LXRX	0.85	-29.70	12.62
2026-03-27	LXRX	0.85	-29.70	12.62
2026-03-30	LXRX	0.85	-29.70	12.62
2026-03-31	LXRX	0.85	-29.70	12.62
2026-04-01	LXRX	0.85	-29.70	12.62
2026-04-02	LXRX	0.85	-29.70	12.62
2026-04-06	LXRX	0.85	-29.70	12.62
2026-04-07	LXRX	0.85	-29.70	12.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

0.85

Institutional Transactions

-29.7

Beta

1.03

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

74.6

Max Drawdown 5-Year %

-95.2

Target Price

3.36

P/E

Forward P/E

PEG

P/S

13.61

P/B

5.41

P/Free Cash Flow

EPS

-0.14

Average EPS Est. Cur. Y

-0.18

EPS Next Y. (Est.)

-0.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-101.08

Relative Volume

0.64

Return on Equity vs Sector %

-74.3

Return on Equity vs Industry %

-57.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

-30.7

◆ LXRX Healthcare

$1.60

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

19/25

Volume

9/15

Valuation

8/20

TP/AR

3/10

Options

8/10

RSI

Range 1M

50%

Sup Dist

2.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

10/30

Estimates

3/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-26.5%

EPS NY

-16.4%

52W%

86.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +110% upside

Quality

7/30

Valuation

16/30

Growth

7/25

Stability

4/10

LT Trend

3/5

Upside

+110%

Quality

Lexicon Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 81

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

LXRX

Latest News

—

Caricamento notizie per LXRX…

stock quote shares LXRX – Lexicon Pharmaceuticals Inc. Stock Price stock today

news today LXRX – Lexicon Pharmaceuticals Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch LXRX – Lexicon Pharmaceuticals Inc. yahoo finance google finance

stock history LXRX – Lexicon Pharmaceuticals Inc. invest stock market

stock prices LXRX premarket after hours

ticker LXRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: LXRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y